Association of inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from Inner Mongolia, China

被引:20
作者
Thompson, Angela M. [1 ]
Zhang, Yonghong [2 ]
Tong, Weijun [2 ]
Xu, Tan [2 ]
Chen, Jing [1 ,3 ]
Zhao, Li [4 ]
Kelly, Tanika N. [1 ]
Chen, Chung-Shiuan [1 ]
Bazzano, Lydia A. [1 ,3 ]
He, Jiang [1 ,3 ]
机构
[1] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA
[2] Soochow Univ, Coll Med, Sch Radiat Med & Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China
[3] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA
[4] Tongliao Ctr Dis Prevent & Control, Tongliao, Inner Mongolia, Peoples R China
基金
中国国家自然科学基金;
关键词
metabolic syndrome; diabetes; inflammation; endothelial dysfunction; C-reactive protein; intercellular adhesion molecule-1; E-selectin; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; OLDER CHINESE; ADHESION MOLECULES; RISK; MARKERS; DEFINITIONS; CHOLESTEROL;
D O I
10.1186/1472-6823-11-16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We examined the association of biomarkers of inflammation and endothelial dysfunction with diabetes and metabolic syndrome (MetS) in persons from Inner Mongolia. Methods: A cross-sectional study was conducted among 2,536 people aged 20 years and older from Inner Mongolia, China. Overnight fasting blood samples were obtained to measure plasma concentrations of high sensitivity C-reactive protein (hsCRP), soluble inter-cellular adhesion molecule-1 (sICAM-1), sE-selectin, angiotensin II, high density lipoprotein cholesterol, triglycerides, and blood glucose. Waist circumference and blood pressure were measured by trained staff. MetS was defined according to the modified ATP III definition for Asians. Elevated level of the biomarker was defined as values in the upper tertile of the distribution. Participants were categorized into one of four groups based on the presence or absence of metabolic and glycemic abnormalities: 1) free of prediabetes, diabetes and MetS (reference group), 2) prediabetes or diabetes only, 3) MetS without prediabetes or diabetes, and 4) MetS plus prediabetes or diabetes. The multivariable models are adjusted for age, gender, smoking, drinking, family history of hypertension, and body mass index. Results: Among study participants, 18.5% had prediabetes, 3.6% had diabetes, and 27.4% of the entire study population had 3 or more components of the MetS. Elevated hsCRP was associated with an increased odds of prediabetes or diabetes only, MetS without prediabetes or diabetes, and MetS plus prediabetes or diabetes with multivariable adjusted odds ratios (95% confidence intervals) of 2.3 (1.7-3.1), 3.0 (2.4-3.8), and 5.8 (4.5-7.5), respectively. Elevated sICAM-1 was associated with increased odds (95% CI) of prediabetes or diabetes only (2.1, 1.6-2.9) and MetS plus prediabetes or diabetes (4.2, 3.2-5.3) but was not associated with MetS alone. Elevated sE-selectin was associated with a modestly increased risk of MetS (OR 1.7, 95% CI 1.4-2.2). Elevated levels of Angiotensin II were not associated with the MetS plus prediabetes or diabetes in this study. Conclusions: Diabetes and the MetS are common in the Inner Mongolia population. The biomarkers of inflammation and endothelial dysfunction are associated with increased risk for diabetes and MetS in this population. These results are consistent with results from other populations.
引用
收藏
页数:8
相关论文
共 37 条
[1]   The metabolic syndrome and chronic kidney disease in US adults [J].
Chen, J ;
Muntner, P ;
Hamm, LL ;
Jones, DW ;
Batuman, V ;
Fonseca, V ;
Whelton, PK ;
He, J .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) :167-174
[2]   Metabolic Syndrome and Diabetes, Alone and in Combination, as Predictors of Cardiovascular Disease Mortality Among Men [J].
Church, Timothy S. ;
Thompson, Angela M. ;
Katzmarzyk, Peter T. ;
Sui, Xuemei ;
Johannsen, Neil ;
Earnest, Conrad P. ;
Blair, Steven N. .
DIABETES CARE, 2009, 32 (07) :1289-1294
[3]   Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes - The Hoorn Study [J].
de Jager, J ;
Dekker, JM ;
Kooy, A ;
Kostense, PJ ;
Nijpels, G ;
Heine, RJ ;
Bouter, LM ;
Stehouwer, CDA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) :1086-1093
[4]   Metabolic syndrome and 10-year cardiovascular disease risk in the hoorn study [J].
Dekker, JM ;
Girman, C ;
Rhodes, T ;
Nijpels, G ;
Stehouwer, CDA ;
Bouter, LM ;
Heine, RJ .
CIRCULATION, 2005, 112 (05) :666-673
[5]  
EMANUEL RL, 1973, J LAB CLIN MED, V81, P632
[6]   The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study [J].
Ford, ES .
ATHEROSCLEROSIS, 2004, 173 (02) :309-314
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]   Metabolic syndrome and risk of cardiovascular disease: A meta-analysis [J].
Galassi, Andrea ;
Reynolds, Kristi ;
He, Jiang .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (10) :812-819
[9]   Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications [J].
Goldberg, Ronald B. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) :3171-3182
[10]  
Grundy SM, 2004, CIRCULATION, V109, P433, DOI [10.1161/01.CIR.0000111245.75752.C6, 10.1161/01.CIR.0000112379.88385.67]